Surface markers and prognostic factors in acute lymphoblastic leukemia

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous disease.
• Surface marker analysis aids in classifying ALL subtypes.
• T-cell ALL (T-ALL) is a distinct subtype with unique clinical features.

Purpose of the Study:

• To investigate the surface markers on lymphoblasts in acute lymphoblastic leukemia patients.
• To correlate T-marker expression with clinical presentation and prognosis.

Main Methods:

• Analysis of lymphoblast surface markers using spontaneous rosette formation with sheep erythrocytes (E rosettes) for T cells.
• Detection of surface immunoglobulin for B cells.
• Classification of lymphoblasts into T-marker, B-marker, and null lymphoblasts.
• Correlation of marker status with clinical data including leukemic infiltration, mediastinal mass, and prognosis.

Main Results:

• Out of 37 patients, 8 had T-marker lymphoblasts, 28 had null lymphoblasts, and 1 had B-marker lymphoblasts.
• T-marker ALL patients frequently presented with massive leukemic infiltration and mediastinal mass.
• T-marker lymphoblasts showed weak/negative periodic acid-Schiff reaction and low antigenic stimulation.
• T-marker ALL was associated with a poor prognosis.

Conclusions:

• T-marker lymphoblasts in acute lymphoblastic leukemia are linked to aggressive disease characteristics.
• The presence of T-marker lymphoblasts, combined with other poor-risk factors, reliably predicts a poor prognosis.
• Surface marker analysis is crucial for stratifying ALL patients and guiding therapeutic approaches.